Semax

Description

Semax is a synthetic heptapeptide analogue of the ACTH(4-7) fragment, modified with a C-terminal Pro-Gly-Pro extension to enhance metabolic stability and CNS activity. In research settings, Semax is studied for its interactions with neurotrophin signaling pathways, BDNF expression modulation, and neuroprotective mechanisms in central nervous system models.

BioRhex supplies Semax as a research compound manufactured in a GMP-compliant US facility, tested to ≥99% purity via HPLC and mass spectrometry, and supplied strictly for controlled laboratory research — not for human or animal use.